论文部分内容阅读
复方醋酸钠注射液系《中国医院制剂规范》(以下简称《规范》)第二版收载的注射剂,临床常用于外伤性休克和感染性休克及溶血性出血热、酸中毒等病症,是一种较理想、安全的体液补充剂。但据调查表明,在配制过程中,如按《规范》的制法,所得的复方醋酸钠注射液的澄明度并不令人满意,其合格率仅为38％。我们从容器包装、洗涤、配制、无菌依次查找原因。通过多次生产试验的摸索,改进配制的操作方法,结果令人满意,现报道如下:
Compound sodium acetate injection is “Chinese Hospital Preparation Specification” (hereinafter referred to as “Code”) contained in the second edition of injection, commonly used in traumatic shock and septic shock and hemolytic hemorrhagic fever, acidosis and other diseases, is a More ideal, safe body fluid supplements. However, according to the survey, according to the “standard” system, the clarity of the compound sodium acetate injection obtained during the formulation process is unsatisfactory and the pass rate is only 38%. We look for the cause from container packaging, washing, dispensing, sterility. Through several trial production trials to improve the formulation of the operation method, the results are satisfactory, are reported as follows: